OMX:CAMX

Camurus AB (publ) Stock Insider Trading

Stockholm Stock Exchange > Healthcare > Biotechnology

kr593.50

-0.500 (-0.0842%)

At Close: Jul 02, 2024

Camurus AB (publ) Stock Insider Power

Based on the 0 latest insides trades, we have calculated the insider power to be negative at 0. In total, the insiders bought 0 and sold 0 CAMX.ST shares in the last 0 trades.

Historical Insider Trades

There is currently no insider trading information for this ticker.

However, we invite you to learn more about this term and how to use this knowledge to benefit your trading strategy:

Sorry! Image not available at this moment

About Camurus AB (publ)

Camurus AB (publ), a pharmaceutical company, develops and commercializes medicines for severe and chronic conditions in Europe, Australia, the United States, Japan, and internationally. The company offers Buvidal, a buprenorphine injection for the treatment of opioid dependence; episil oral liquid, a medical device for the treatment of inflammatory and painful conditions in the oral cavity; and Brixadi to treat opioid use disorder Its products pi... CAMX.ST Profile

Golden Star

Ticker	Date	Change	Price
RDN	Jun 28	1.45%	$31.10
LNT	Jun 28	0.393%	$50.90
PDBC	Jun 28	1.21%	$14.05
SLM	Jun 28	0.481%	$20.79
TXN	Jun 28	2.00%	$194.53
TRMB	Jun 28	0.536%	$55.92
VIGI	Jun 28	0.185%	$81.28
GFS	Jun 28	0.554%	$50.56
SF	Jun 27	3.42%	$80.65
PRK	Jun 27	4.48%	$137.14

Unlock

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by

Sign In